Agilent Technologies Inc.

A Stock Report Card

Today's performance

69%

Performance

Score:

100/100

A returned 1.33% in the last 12 months. Based on SPY's performance of -8.69%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

Score:

82/100

14 analysts offer 12-month price targets for A. Together, they have an average target of 167.75, the most optimistic target put A at 170 within 12-months and the most pessimistic has A at 161. These analyst ratings are from our partners at Financial Modeling Prep (https://site.financialmodelingprep.com/) and Alpha Vantage (https://www.alphavantage.co/).

Sentiment

Score:

68/100

A had a bullish sentiment score of 68.00% across Twitter and StockTwits over the last 12 months. It had an average of 110.82 posts, 623.30 comments, and 1,939.79 likes per day.

Technicals

Score:

50/100

A receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

Earnings

Score:

100/100

A has missed earnings 1 times in the last 20 quarters.

Profit

Score:

63/100

Out of the last 20 quarters, A has had 20 profitable quarters and has increased their profits year over year on 6 of them.

Volatility

Score:

45/100

A has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

Dividend

Score:

41/100

A's most recent dividend was $0.15 per share, based on a share price of $119.35. It was a payout ratio of 20.34% compared to their total earnings.

Agilent Technologies Inc. Summary

New York Stock Exchange / A

Healthcare

Diagnostics & Research

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Pluto is a technology provider that provides you with information, software, and automation tools for the purpose of investment education, but it does not make investment recommendations of securities, investment strategies, or account types, either in general or individualized for you or any other subscriber. If you want to receive individualized investment advice, you should consult with your own financial adviser. Pluto also does not provide you with legal, tax, or accounting advice. You agree that you understand that Pluto is not an investment adviser or a broker-dealer and does not have a fiduciary duty to you or a duty to act in your best interests. Pluto can help you back-test the historical performance of strategies that you create, but it does not recommend strategies and reminds you that the historical performance of a strategy is not a reliable predictor of future results for that strategy. Pluto uses third-party information, for example, about securities market data, that it reasonably believes to be reliable, but it does not warrant that the information is complete, accurate, or up-to-date, and as discussed further below, Pluto does not provide any warranty of merchantability or warranty for a particular purpose for that third-party market data or other information. Investing involves risk, including the risk of loss, and you should not use the Pluto technology in connection with investments unless you are able to and intend to evaluate the technology and the risks and make your own self-directed investment decisions.

Power up your portfolio

Build a portfolio of your favorite stocks

Pluto makes it easy to build investing strategies and automate your portfolio

See how

Checkout Similar Companies

A scored highly on our reportcard. Here are some similar companies and how they performed.

Eli Lilly & Co.

$LLY Stock Report Card

ABBVIE INC.

$ABBV Stock Report Card

Biogen Inc. Common Stock

$BIIB Stock Report Card

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$HLN Stock Report Card

GE HealthCare Technologies Inc. Common Stock

$GEHC Stock Report Card

Seagen Inc. Common Stock

$SGEN Stock Report Card

Centene Corporation

$CNC Stock Report Card

View all stock report cards

Los Angeles, CA

Pluto is not a broker-dealer, investment adviser or member of FINRA. Securities offered by Alpaca Securities LLC (“Alpaca Securities”). Alpaca Securities is a member of FINRA and the Securities Investor Protection Corporation.

Alpaca Securities, LLC (“Alpaca Securities”) is not responsible for and is not providing the technology and services you receive from us to access and manage your brokerage account with Alpaca Securities. You firmly agree to hold Alpaca and its affiliates, owners, directors, employees, clearing firm and agents harmless for any loss or damage arising from the use of or unavailability of the technology and services that we are providing.

The content on this website is for informational purposes only. Pluto does not recommend any specific securities or investment strategies. Investing involves risk & investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing.